Taiwan FDA registration 2150f0ea7c15232ec4e878600c7df071
RAMP TroponinⅠAssay
TW: “倫普” 肌鈣蛋白Ⅰ檢驗試劑組
Taiwan·Risk Class 2·MD·RESPONSE BIOMEDICAL CORPORATION·Registered Nov 02, 2015 – Nov 02, 2025ExpiredRegistration details
- Analysis ID
- 2150f0ea7c15232ec4e878600c7df071
- License Form
- Ministry of Health Medical Device Import No. 027892
- Customs Code
- DHA05602789201
Company information
- Manufacturer
- RESPONSE BIOMEDICAL CORPORATION
- Manufacturer Country
- Canada
- Authorized Representative
- RECHI CO., LTD.
Product details
- Intended Use
- This product is an in vitro diagnostic product used in combination with RAMP Reader System or RAMP 200 system using quantitative immunochromatography, used to detect Troponin І concentration in EDTA whole blood.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1215 Creatine phosphocatalyzed?/creatine excitation or isomeric test system
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Nov 02, 2015
- Expiry Date
- Nov 02, 2025
About this record
Access comprehensive regulatory information for RAMP TroponinⅠAssay in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2150f0ea7c15232ec4e878600c7df071 and manufactured by RESPONSE BIOMEDICAL CORPORATION. The authorized representative in Taiwan is RECHI CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices